Gene: PIGQ
Official Full Name: phosphatidylinositol glycan anchor biosynthesis class Qprovided by HGNC
Gene Summary: This gene is involved in the first step in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes a N-acetylglucosaminyl transferase component that is part of the complex that catalyzes transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33602 | PIGQ Knockout cell line (HeLa) | Human | PIGQ | 1:3~1:6 | Negative | Online Inquiry |
KO33603 | PIGQ Knockout cell line (HCT 116) | Human | PIGQ | 1:2~1:4 | Negative | Online Inquiry |
KO33604 | PIGQ Knockout cell line (HEK293) | Human | PIGQ | 1:3~1:6 | Negative | Online Inquiry |
KO33605 | PIGQ Knockout cell line (A549) | Human | PIGQ | 1:3~1:4 | Negative | Online Inquiry |
PIGQ Gene Knockout Cell Lines are engineered cellular models that have been specifically developed to facilitate the functional analysis of the PIGQ gene, which is involved in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. These cell lines provide a powerful tool for studying the implications of GPI anchoring on cell signaling, adhesion, and immune response by creating a controlled environment where the PIGQ gene is inactivated.
The key function of PIGQ Gene Knockout Cell Lines is to serve as a platform for investigating the downstream effects of GPI anchor deficiency. The knockout of the PIGQ gene impairs the synthesis of GPI anchors, leading to the accumulation of unanchored proteins and allowing researchers to observe alterations in cellular behavior, including changes in membrane integrity and interaction with extracellular matrix components. This valuable mechanism not only elucidates gene function but also assists in understanding associated pathologies, such as immune deficiencies and certain genetic disorders.
In research and clinical settings, these knockout cell lines have significant scientific importance. They hold the potential to advance our understanding of various diseases, including cancer and autoimmune disorders, by revealing the critical roles of GPI-anchored proteins. Moreover, they can be utilized for drug screening, toxicity studies, and the exploration of therapeutic strategies targeting GPI anchor-related pathways.
What sets PIGQ Gene Knockout Cell Lines apart from alternative models is their precise genetic modification, ensuring reproducibility, specificity, and gene expression control, factors essential for reliable experimental outcomes. Additionally, these cell lines can be easily adapted for high-throughput assays, increasing efficiency in research workflows.
Researchers and clinicians can leverage the value of PIGQ Gene Knockout Cell Lines to explore unexplored biological pathways, validate therapeutic targets, and ultimately enhance translational research efforts. Our company is committed to providing high-quality biological products backed by a team of experts dedicated to advancing scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.